The IVF laboratory is where fertilisation happens, where embryos develop for 5–6 days, and where the quality of that development determines whether viable blastocysts reach transfer. The lab is, in a very real sense, where the outcome of a cycle is most directly shaped — more so than the consultant's protocol, the nurse coordinator's communication style, or the clinic's waiting room.

Yet laboratory quality is almost entirely invisible to patients. There is no standardised public reporting of embryology lab performance in the UK beyond the outcome data the HFEA publishes. This guide explains what to look for and what to ask.

What Happens in the IVF Lab

The embryology laboratory is responsible for:

  • Egg assessment: Identifying which collected eggs are mature (metaphase II) and suitable for fertilisation
  • Sperm preparation: Washing and selecting sperm for IUI, IVF, or ICSI
  • ICSI: The microinjection of a single sperm into each mature egg
  • Embryo culture: Maintaining embryos in culture media, incubators, and controlled conditions for 5–6 days
  • Blastocyst selection: Grading and selecting the best embryo(s) for transfer or freezing
  • Vitrification: Rapid freezing of surplus embryos and eggs
  • Thawing: Warming frozen embryos or eggs for FET cycles
  • Biopsy (for PGT): Taking cells from the trophectoderm for genetic testing

The quality of each step — the equipment, the culture media, the expertise of the embryologist, the air quality in the lab — affects how many eggs fertilise, how many embryos develop to blastocyst, and ultimately how many viable embryos are available for transfer.

What Distinguishes a High-Quality Lab

Air quality and volatile organic compounds (VOCs). Embryos are exquisitely sensitive to VOC contamination in the air. High-quality labs invest heavily in air filtration and purification systems, and some use positive-pressure laminar flow systems to exclude contaminants. Many clinics have moved to purpose-built buildings or refurbished lab spaces for this reason.

Culture media. Embryos are cultured in commercial media that supplies the nutrients, growth factors, and pH balance they need. Different media products exist; lab performance can vary depending on which is used and how it is handled. Labs regularly validate their media choices against internal performance data.

Incubators. Modern incubators maintain precise temperature, CO₂, and oxygen levels around individual embryos. Time-lapse incubators (such as EmbryoScope) allow continuous monitoring without removing embryos from their controlled environment — reducing exposure to ambient conditions and enabling detailed developmental tracking.

Embryologist experience and caseload. The skill of the individual embryologist performing ICSI and biopsy is a real variable. A lab where each embryologist performs many cases per year typically produces more consistent results than one where volume is low and skills are infrequently exercised.

Lab opening hours. Egg collection can fall on any day of the week — labs must be staffed at weekends. A clinic that only operates the embryology lab on weekdays cannot manage egg collections on a Saturday.

Key Metrics to Ask About

Most clinics should be able to provide these performance figures on request:

Blastocyst development rate: The percentage of fertilised (2PN) eggs that develop to blastocyst (Day 5–6). Typical range across competent labs: 40–60%. Below 35% consistently suggests a lab quality issue. Above 60% suggests excellent conditions.

Fertilisation rate (ICSI): The percentage of injected mature eggs that fertilise normally (2PN). Typically 60–75%. Significantly below 60% is a concern.

Vitrification survival rate: The percentage of vitrified embryos or eggs that survive the thaw. Typically 90%+ for good-quality blastocysts, 80–90% for mature eggs.

Biopsy survival rate (if PGT): The percentage of biopsied blastocysts that survive the process with quality intact. Should be 95%+.

Metrics the HFEA Publishes (and What They Miss)

The HFEA publishes live birth rates per transfer by clinic, which reflects both lab performance and clinical protocol quality. However, HFEA data does not show:

  • Blastocyst development rate (only outcome data)
  • Cancellation rate (cycles where no embryos reached transfer)
  • Per-egg-collected success rate (which better captures lab efficiency)

This is why the HFEA data is a necessary but insufficient assessment of lab quality. Comparing clinic success rates by age bracket gives some signal, but clinics with high-quality labs that also accept more difficult cases may appear to underperform against clinics with less challenging patient populations.

Red Flags for Lab Quality

  • No time-lapse incubation available. Most high-volume modern labs have at least some time-lapse capacity. Its complete absence isn't a disqualifier, but it's worth understanding why.
  • Blastocyst development rate below 35%. Ask specifically and compare against industry norms.
  • The lab is in an older building with no mention of air quality management. In older facilities, VOC contamination from building materials and furnishings is a genuine concern.
  • Very low case volume. Labs that do fewer than 100 cycles per year may have less consistent embryologist experience.
  • No on-site laboratory — some small fertility units send samples to a centralised lab, which introduces transport and timing issues.

Frequently Asked Questions

Q: How can I assess lab quality if the clinic won't share performance data?

A: This is itself informative. A clinic that refuses to share blastocyst development rates or fertilisation rates is either underperforming or not tracking these metrics rigorously. Compare with a clinic that shares data openly. Asking for a lab tour (where sterile precautions allow) is another option — some clinics offer viewing windows or virtual tours.

Q: Does using time-lapse incubation improve my chances?

A: The HFEA rates time-lapse with AI selection as an add-on with limited evidence of benefit on live birth rates. The clinical benefit of time-lapse over standard incubation may be modest for most patients. However, time-lapse does reduce embryo exposure to ambient conditions (by not opening incubators for observation) — a genuine laboratory advantage. The net clinical benefit in well-run labs may be small because standard incubator quality is high. It is a reasonable feature to look for but not a deal-breaker.

Q: Can I request that a specific embryologist performs my ICSI?

A: In most clinics, you cannot request a specific embryologist for your cycle — scheduling is managed by the lab and depends on who is on shift on collection day. However, asking about how many embryologists work in the lab and their experience level is reasonable.

Q: My blastocyst development rate was very low in a previous cycle. What should I ask?

A: Ask the clinic what their average blastocyst development rate is and how yours compares. If your rate was below their average, ask whether they think it reflects egg quality, sperm quality, or lab conditions. If you are considering a second opinion, asking a new clinic to review your embryology notes is one of the most valuable things you can do.

Q: Does the type of culture media matter?

A: Yes, but the differences between modern commercial media products are modest in most situations and are not something patients can meaningfully evaluate. This is more relevant if you are comparing clinics and one is using a media product with a documented quality issue (rare, but has occurred with specific batches historically). The more meaningful question is whether the clinic validates and monitors its media performance consistently.

This article is for information only and does not constitute medical advice. Discuss laboratory standards with your clinic during the consultation process.